Heart lasso: new catheter belt tightens leaky valve without surgery

NCT ID NCT06479824

Terminated Disease control Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a new procedure called TRAIPTA for people with severe tricuspid valve regurgitation, a condition where a heart valve leaks and causes breathlessness and fluid buildup. The procedure uses a catheter to place a belt-like device around the heart from inside, tightening the valve to reduce leakage. The study will enroll 60 adults who cannot have standard surgery and will follow them for a year to check safety and heart function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: TRAIPTA device (a catheter-placed belt around the heart to tighten the leaky tricuspid valve)
What this could lead to: If it works, this could offer a less invasive option for people with severe tricuspid valve leakage who cannot have open-heart surgery.
What could go wrong: This is a very early feasibility study with only 60 participants, so it is not yet proven safe or effective. The procedure involves puncturing the heart and placing a permanent belt, which carries risks like bleeding, heart compression, or device-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID VALVE INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tricuspid valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRICUSPID VALVE INSUFFICIENCY

Contacts and locations

Locations

Emory University

Atlanta, Georgia, 30308, United States
St. Francis Hospital and Heart Center

Roslyn, New York, 11576, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.